AMITRIPTYLINE 10 & 50mg: NDMA and NNORT impurity
What the notice records
| Product | AMITRIPTYLINE 10 & 50mg |
|---|---|
| Issue | Contamination |
| What you should do | Continue taking your medication.Not treating a condition may pose a greater health risk than potential nitrosamine exposure.Contact your health care provider:to discuss treatment options if you're using a recalled productif you have taken a recalled product and are concerned about your healthAsk your pharmacist if you're not sure if the product you're taking has been recalled. |
| Category | Drugs |
| Publishing body | Drugs and health products |
| Class | Class 1 |
| Last updated | 2023-08-16 |
Read the official notice on recalls-rappels.canada.ca
Everything in Drugs · Everything from Drugs and health products
Read this correctly
This page reproduces the fields published on the notice and links to the notice itself. It is not a rating and not a statement about a product's current condition, availability or safety.
The class recorded here is the publisher's own classification. What it means is defined by Health Canada's recall classes.
Privacy
This site publishes records that governments already publish. It sets no cookie and makes no request to Google unless you accept one. Read more below.
About this record
Every recall notice published by Health Canada: the product, the issue recorded against it, the class assigned, and the official notice itself. A record of what was published, on the date it was published.
Source: Health Canada — Recalls and safety alerts (open data) — Open Government Licence – Canada. Data refreshes daily. Every page links the row it came from.
What this site is not. It is a copy of an official record. It is not a judgement about any business, building or person, and it is not advice. If the record is wrong, the source above is where it is corrected.